Aurora and WeedMD Announce Strategic Agreement

Aurora Cannabis Inc. (ACB.V) (ACBFF) (Frankfurt:21P; WKN:A1C4WM) and WeedMD Inc. (“WeedMD”) (WMD.V) are pleased to announce that the companies have entered into a strategic relationship whereby WeedMD will provide wholesale dried medical cannabis to Aurora, and Aurora will provide best in class patient education services for WeedMD through its cannabis counselling and outreach unit CanvasRx., Inc. (CIIX) Set to Launch New Skin Care Line in Q3 2017

Market analysis company, Inc. (OTCQB: CIIX) this morning announced that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., will officially launch its first line of non-industrial hemp infused skin care products, the ‘CBD Magic Hemp Series’, in the third calendar quarter of 2017.

Market Data Shows Growth in the Cannabis Industry

According to a recent report by New Frontier Data, the Viridian Cannabis Stock Index gained 236.1% in 2016, or outperforming such mainstream indexes as the Russell 2000 (up 19.5%), the Dow Jones Industrial Average (up 13.4%), the S&P 500 (up 9.5%), and the Nasdaq composite (up 7.5%).

Canopy Growth Provides Global Operational Update

Canopy Growth Corporation ( TSX: WEED )), is pleased to provide the following significant summary of updates to inform shareholders and stakeholders of activities and developments across the global organization.

Pot stocks: Is now the time to invest in medical marijuana?

An air of optimism is brewing around Canada's cannabis sector. In Alberta, a cannabis company is breaking ground this week on an 800 square-foot, state-of-the-art medical marijuana greenhouse near Edmonton. Then, another startup out of Okotoks will launch an online marketplace, called on Saturday. But is now the right time to buy into the hype and invest in this growing industry?

The Global Legal Cannabis Industry is Expected to Gain Momentum

According to a research published by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016. The market is forecast to grow at a CAGR of 21.1% between 2017 and 2024, while culminating in 2024 global sales of $63.5 billion . The legal cannabis market is witnessing robust growth owing to the increasing legalization and decriminalization of marijuana across North America and Europe .

India Globalization Capital, Inc. (NYSE: IGC) Becomes Exclusive Licensee of Cannabis-Based Treatment for Alzheimer’s Disease

​India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its entry into a definitive license agreement with the University of South Florida that makes the company the exclusive licensee of the U.S. patent filing entitled ‘THC as a Potential Therapeutic Agent for Alzheimer’s Disease’.